These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29306636)

  • 1. Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease.
    Ten Harmsen BL; van Rumund A; Aerts MB; Bergkamp MI; Esselink RAJ; Richard E; Meijer FJA; Bloem BR; van Wamelen DJ
    Parkinsonism Relat Disord; 2018 Apr; 49():28-33. PubMed ID: 29306636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.
    Heinrich J; Vidal JS; Simon A; Rigaud AS; Hanon O; Epelbaum J; Viollet C; Duron E
    J Alzheimers Dis; 2018; 61(3):1133-1141. PubMed ID: 29332036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders.
    Robertson AD; Messner MA; Shirzadi Z; Kleiner-Fisman G; Lee J; Hopyan J; Lang AE; Black SE; MacIntosh BJ; Masellis M
    Parkinsonism Relat Disord; 2016 Jan; 22():80-6. PubMed ID: 26639982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential spatial distribution of white matter lesions in Parkinson's and Alzheimer's diseases and cognitive sequelae.
    Grey MT; Mitterová K; Gajdoš M; Uher R; Klobušiaková P; Rektorová I; Rektor I
    J Neural Transm (Vienna); 2022 Aug; 129(8):1023-1030. PubMed ID: 35819634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
    Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral autoregulation and white matter lesions in Parkinson's disease and multiple system atrophy.
    Indelicato E; Fanciulli A; Poewe W; Antonini A; Pontieri FE; Wenning GK
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1393-7. PubMed ID: 26578037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.
    Veselý B; Antonini A; Rektor I
    J Neural Transm (Vienna); 2016 Mar; 123(3):241-50. PubMed ID: 26483133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature.
    Veselý B; Rektor I
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S166-70. PubMed ID: 26391185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease.
    Park YW; Shin NY; Chung SJ; Kim J; Lim SM; Lee PH; Lee SK; Ahn KJ
    Mov Disord; 2019 Nov; 34(11):1672-1679. PubMed ID: 31322758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of white matter lesions in Parkinson's disease using automated multi-modal segmentation measures.
    Fang E; Fartaria MJ; Ann CN; Maréchal B; Kober T; Lim JX; Ooi LQR; Chen C; Lim SL; Tan EK; Chan LL
    J Neurol Sci; 2021 Aug; 427():117518. PubMed ID: 34118693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.
    Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V
    J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of leukoaraiosis and the clinical severity of vascular Parkinsonism.
    Chen YF; Tseng YL; Lan MY; Lai SL; Su CS; Liu JS; Chang YY
    J Neurol Sci; 2014 Nov; 346(1-2):255-9. PubMed ID: 25240444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between white matter lesions and cerebral Aβ burden.
    Yi HA; Won KS; Chang HW; Kim HW
    PLoS One; 2018; 13(9):e0204313. PubMed ID: 30248123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between White Matter Lesions and Non-Motor Symptoms in Parkinson Disease.
    Lee JY; Kim JS; Jang W; Park J; Oh E; Youn J; Park S; Cho JW
    Neurodegener Dis; 2018; 18(2-3):127-132. PubMed ID: 29870975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of white matter lesions to cognitive decline in Parkinson's disease.
    Grey MT; Veselý B; Gajdoš M; Klobušiaková P; Rektor I
    Parkinsonism Relat Disord; 2019 Apr; 61():248-249. PubMed ID: 30343982
    [No Abstract]   [Full Text] [Related]  

  • 16. White matter changes and the development of motor phenotypes in de novo Parkinson's Disease.
    Moccia M; Tedeschi E; Ugga L; Erro R; Picillo M; Caranci F; Barone P; Brunetti A
    J Neurol Sci; 2016 Aug; 367():215-9. PubMed ID: 27423590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders.
    Pilotto A; Romagnolo A; Scalvini A; Masellis M; Shimo Y; Bonanni L; Camicioli R; Wang LL; Dwivedi AK; Longardner K; Rodriguez-Porcel F; DiFrancesco M; Vizcarra JA; Montanaro E; Maule S; Lupini A; Ojeda-López C; Black SE; Delli Pizzi S; Gee M; Tanaka R; Yamashiro K; Hatano T; Borroni B; Gasparotti R; Rizzetti MC; Hattori N; Lopiano L; Litvan I; Espay AJ; Padovani A; Merola A
    Neurology; 2021 Aug; 97(8):e814-e824. PubMed ID: 34099524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periventricular White Matter Lesions Influence Gait Functions in Parkinson's Disease.
    Toda K; Iijima M; Kitagawa K
    Eur Neurol; 2019; 81(3-4):120-127. PubMed ID: 31203285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent cognitive and affective differences in Alzheimer's and Parkinson's diseases in relation to MRI findings.
    Tokuchi R; Hishikawa N; Sato K; Hatanaka N; Fukui Y; Takemoto M; Ohta Y; Yamashita T; Abe K
    J Neurol Sci; 2016 Jun; 365():3-8. PubMed ID: 27206864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?
    McDonald C; Newton JL; Burn DJ
    Mov Disord; 2016 Jul; 31(7):937-46. PubMed ID: 27091624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.